| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 78.70M | — |
| Operating expense | — | — |
| Net income | 17.29M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RIGL returned +10.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +7.1% |
| 1 year | +10.6% |
| 5 years | +20.8% |
| 10 years | +36.2% |
| All-time high | $900.00 (Dec 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RIGL would be worth today ›No. Rigel Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Rigel Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol RIGL.
Rigel Pharmaceuticals, Inc. is part of the Healthcare sector.
Rigel Pharmaceuticals, Inc. has a market cap of 857.22M USD, based on the latest quote.
Rigel Pharmaceuticals, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
